HIV/AIDS

Higher Viral Control in Women With HIV in Serodiscordant Relationships

Higher Viral Control in Women With HIV in Serodiscordant Relationships

By

Viral control is more prevalent in infected partners in HIV-serodiscordant couples compared with PLWHIV who are not in a similar relationship.

HIV Control Criteria: Overview & Expert Roundtable

HIV Control Criteria: Overview & Expert Roundtable

By

Although the overall number of new HIV infections has declined worldwide, it is estimated that 5000 new infections occur each day.

Dolutegravir Plus Lamivudine Promising for HIV Maintenance Therapy

Dolutegravir Plus Lamivudine Promising for HIV Maintenance Therapy

By

For PLWHIV who achieve virologic suppression, dolutegravir plus lamivudine may be a safe and effective maintenance therapy.

Study to Test Efficacy of Liposomal Amphotericin for Cryptococcal Meningitis

Study to Test Efficacy of Liposomal Amphotericin for Cryptococcal Meningitis

By

Researchers plan to conduct a study examining whether a single high dose of liposomal amphotericin with high-dose fluconazole and flucytosine is noninferior to amphotericin.

Rx Opioids Up Pneumonia Risk in Patients With, Without HIV

Rx Opioids Up Pneumonia Risk in Patients With, Without HIV

Risk greatest with higher-dose opioids and opioids with immunosuppressive properties

HIV & Cancer Risk: Expert Interview

HIV & Cancer Risk: Expert Interview

By

Although rates of AIDS-defining malignancies have declined in recent decades, cancer remains a leading cause of mortality in people living with HIV.

Urokinase Plasminogen Receptor Levels Linked to Non-AIDS Related Events During ART Viral Suppression

Urokinase Plasminogen Receptor Levels Linked to Non-AIDS Related Events During ART Viral Suppression

In patients with HIV, elevated levels of soluble urokinase plasminogen activator receptor are associated with non-AIDS events.

Sleep Abnormalities Do Not Reverse After Discontinuing Efavirenz

Sleep Abnormalities Do Not Reverse After Discontinuing Efavirenz

By

For patients with HIV receiving efavirenz-based therapy, sleep and neuropsychological abnormalities do not readily reverse after discontinuation of treatment.

Kaposi's Sarcoma-Associated Herpes Virus Drives its Pathogenesis

Kaposi's Sarcoma-Associated Herpes Virus Drives its Pathogenesis

By

Patients with epidemic and endemic KS have similar antibody and cytokine responses, suggesting that KS-associated herpes virus drives KS pathogenesis.

HIV/STI Counseling and Testing for Patients on PrEP

HIV/STI Counseling and Testing for Patients on PrEP

By

Further efforts are needed to educate and prepare healthcare providers to prescribe PrEP and manage patients on PrEP to reduce the risk for acquiring HIV.

Partner-Delivered HIV Self-Testing Can Up Linkage to Care

Partner-Delivered HIV Self-Testing Can Up Linkage to Care

HIVST and reminder phone calls or financial incentives increase HIV testing, care.

Interrupted ART in HIV-Exposed Children Reduces Measles Vaccine Efficacy

Interrupted ART in HIV-Exposed Children Reduces Measles Vaccine Efficacy

By

Children with HIV who had ART that was interrupted at either age 12 or 24 months have lower measles antibody geometric mean titers.

Antiretroviral Resistance Testing in People With HIV May Not Be Beneficial

Antiretroviral Resistance Testing in People With HIV May Not Be Beneficial

By

Antiretroviral drug resistance testing may not benefit people who have HIV, specifically in terms of mortality risk and disease progression.

Population Based Screening Crucial for Early Diagnosis/Treatment of STIs

Population Based Screening Crucial for Early Diagnosis/Treatment of STIs

By

Adopting suitable protocols for the early diagnosis of STIs is necessary to allow implementation of prevention measures that will safeguard public health.

Temporary Decline in CD4 T-Cell Count After Hepatitis C Infection in PLWHIV

Temporary Decline in CD4 T-Cell Count After Hepatitis C Infection in PLWHIV

By

When hepatitis C is acquired in patients with HIV infection, CD4 T-cell counts temporarily decline after HCV seroconversion.

GlycA: A Novel Biomarker for CVD Risk in People With HIV

GlycA: A Novel Biomarker for CVD Risk in People With HIV

By

GlycA levels are higher in men with HIV compared with men with do not have HIV.

Not All Patients Prefer Delivery of STI/HIV Screening Results Via SMS

Not All Patients Prefer Delivery of STI/HIV Screening Results Via SMS

By

The delivery of STI/HIV screening results via SMS is well accepted but does not suit all patients.

Potential of HIV-Protective Drugs Administered Via Rectal Douches

Potential of HIV-Protective Drugs Administered Via Rectal Douches

By

Rectal douches could be a viable option to deliver HIV-protective drugs to men who practice receptive anal intercourse with other men.

Similar Measles Seroprevalence in People With and Without HIV

Similar Measles Seroprevalence in People With and Without HIV

By

Similar measles seroprevalence found across PLWHIV and people who do not have HIV, suggesting that PLWHIV do not need an additional dose of a measles vaccine.

Effect of HIV Pretreatment Drug Resistance on Virologic Outcomes

Effect of HIV Pretreatment Drug Resistance on Virologic Outcomes

By

Dual-class pretreatment drug resistance to first-line tenofovir/emtricitabine/efavirenz regiment may be associated with poorer virologic suppression.

Worse Outcomes From <i>Legionella</i> Pneumonia in Individuals With Advanced HIV

Worse Outcomes From Legionella Pneumonia in Individuals With Advanced HIV

By

Previous results stated that Legionella pneumonia characteristics may not differ between individuals with HIV and individuals who do not have HIV.

Greater Temporal Summation of Pain in HIV With Chronic Pain

Greater Temporal Summation of Pain in HIV With Chronic Pain

By

Individuals with HIV and chronic pain may have greater temporal summation of pain compared with healthy individuals or those with HIV but no chronic pain.

More People Worldwide Now Know Their HIV Status

More People Worldwide Now Know Their HIV Status

However, millions of people still do not know their status and do not have a suppressed viral load.

Biologic Agents Used to Treat Patients With Psoriasis and HIV Infection

Biologic Agents Used to Treat Patients With Psoriasis and HIV Infection

By

Investigators evaluated the safety and effectiveness of conventional therapy with biologic immunosuppressive drugs to treat patients with HIV infection and psoriasis.

Barriers to Prevention, Eradication of HIV Remain Despite Numerous Advances

Barriers to Prevention, Eradication of HIV Remain Despite Numerous Advances

By

Since the first clinical observation of HIV/AIDS in 1981, some 35.4 million people have died from AIDS-related illnesses.

Elevated PCSK9 Levels Associated With Coronary Endothelial Dysfunction in PLWHIV

Elevated PCSK9 Levels Associated With Coronary Endothelial Dysfunction in PLWHIV

By

Increased proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in people with HIV may be related to abnormal coronary endothelial function.

Lamivudine/Tenofovir Disoproxil Approved for the Treatment of HIV-1 Infection

Lamivudine/Tenofovir Disoproxil Approved for the Treatment of HIV-1 Infection

By

The FDA has approved Temixys tablets for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in patients weighing ≥35kg.

Increased Risk of Meningococcal Disease in Men Who Have Sex With Men

Increased Risk of Meningococcal Disease in Men Who Have Sex With Men

By

Men who have sex with men have an increased risk of meningococcal disease, however, this risk is under-ascertained and improved surveillance is needed.

USPSTF Suggests Universal HIV Screening, PrEP for High-Risk Patients

USPSTF Suggests Universal HIV Screening, PrEP for High-Risk Patients

Screening recommended for those ages 15 to 65 years, including pregnant women.

Increased Risk for First and Second Primary Cancers in Patients With HIV/AIDS

Increased Risk for First and Second Primary Cancers in Patients With HIV/AIDS

By

Increased cancer prevention, screening, and treatment are needed for people living with HIV both before and after an initial cancer diagnosis.

Sign Up for Free e-newsletters